Medtronic plc

Welcome to Medtronic's Fiscal Year 2021 Second Quarter Earnings Video Webcast. I'm Ryan Weissfenning, Vice President and Head of Medtronic Investor Relations. Before we start the prepared remarks, I'm going to share with you a few details to keep in mind about today's webcast. Joining me are Jeff Martha, Medtronic Chief Executive Officer, and Karen Parkhill, Medtronic Chief Financial Officer. Jeff and Karen will provide comments on the results of our second quarter, which ended on October 30, 2020. After our prepared remarks, we'll take questions from the sell-side analysts that cover the company. Today's event should last about an hour. Earlier this morning, we issued a press release containing our financial statements and a divisional and geographic revenue summary. We also posted an earnings presentation that provides additional details on our performance, which can be accessed from our earnings press release or on our website at investorrelations.medtronic.com. During today's webcast, many of the statements we make may be considered forward-looking statements, and actual results may differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports and other filings that we make with the SEC, and we do not undertake to update any forward-looking statement. Unless we say otherwise, all comparisons are on a year-over-year basis and are given on an organic basis, which adjusts for foreign currency. There were no acquisitions made in the last year that had a significant impact on our quarterly revenue growth. All references to share gains or losses are on a calendar quarter basis, unless otherwise stated. Finally, reconciliations of all non-GAAP financial measures can be found on the attachment to our earnings press release. or on our website at investorrelations.medtronic.com. And with that, let's get started.

Say goodbye to multiple daily insulin injections with the new Omnipod 5, the only tubeless automated insulin delivery system that integrates with Dexcom G6, automatically adjusting your insulin to help protect against highs and lows day or night. Don't wait to simplify life with diabetes. Get started today with no contract and no commitment. Go to Omnipod.com for risk information and instructions for use. Consult your healthcare provider before starting on Omnipod. Simplify diabetes. Simplify life.

Omnipod.